Sonivate Medical

Sonivate has a disruptive, proprietary, FDA-cleared medical imaging technology that addresses critical needs in the $7B ultrasound market.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Portland, OR, USA
  • Currency USD
  • Founded August 2001
  • Employees 7
  • Website sonivate.com

Company Summary

Sonivate Medical (SMI) develops and markets innovative ultrasound technology. The company's technology opens new markets for ultrasound by extending its use into new classes of procedures and new clinical settings. The SonicEye™, SMI’s first product, is a fingertip-mounted ultrasound probe that combines ultrasound imaging with simultaneous tactile feedback, while leaving both hands free to do work. 2012 BVC, 2013 WAC launch company winners.

Team

  • David G. Starr
    President and CEO

    Mr. Starr has over 30 years of marketing and operations experience with medical and consumer devices. Mr. Starr was part of the original DeskJet printer introduction team that presided over rapid growth. At HP Medical he developed the Defibrillator strategy that led to tremendous market growth. He has held senior management positions at Inovise Medical (co-founder) and Hewlett-Packard. BA, Cum Laude, Pomona College. MBA, University of Chicago.

  • Scott Corbett
    Chief Technology Officer

    Scott Corbett has over 30 years experience as a biomedical engineer/executive in the medical device industry and co-founded two Seattle-based biomedical companies, MicroConnex and Advanced Cochlear Systems. He has held senior engineering/management positions at Precision Interconnect (now Tyco Healthcare), and GE Medical Ultrasound Division. B.S. Physics, Occidental College, M.S. Acoustics, Pennsylvania State University.

  • Elizabeth Ettling
    Chief Financial Officer

    Ms. Ettling has served on the management teams for three rapidly growing start up enterprises in the Portland area. Her experience includes building corporate infrastructure, human resource management, corporate governance, finance, tax and operations. She has assisted in raising venture capital and was also integrally involved with two initial public offerings. BS, California State University Los Angeles, Business Administration.

  • Ronald W. Schutz
    Chief Medical Officer

    Dr. Schutz is a board certified cardiologist and Fellow of the American College of Cardiology with nearly 30 years experience in cardiac ultrasound. In 1982 he founded Heart Sounds, Inc., a leading echocardiography service provider to hospitals and clinics and remains its President. He has developed other medical devices that resulted in successful start-up ventures. B.S., Phi Beta Kappa, and MD, University of Illinois.

  • Director of RA / QA and operations

    Ms. Pointer directs Sonivate's Quality and Regulatory efforts. She oversees interactions and submissions made to Regulatory Agencies, such as the FDA. She manages Operations, including Production, Supply Chain and Procurement. During her seventeen year career in the medical device industry, she has held positions with Care Innovations, QuantRx Biomedical and OraSure Technologies. She has a degree in Biology from Oregon State University.

Advisors

  • Michael Phillips
    Lawyer
    Unconfirmed
    Peter Buss
    Accountant
    Unconfirmed

Previous Investors

  • Various physicians and individual investors
    Unconfirmed
    The management team
    Unconfirmed
    Grants from US Dept. of Defense
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free